Wordt geladen...
Analysis of hematological parameters as prognostic markers for toxicity and survival of (223)Radium treatment
(223)Radium ((223)Ra) has emerged as treatment prolonging survival in patients with metastatic castration-resistant prostate cancer (CRPC). As (223)Ra can cause hematotoxicity (HT), pre-existing hematopoiesis might influence the efficacy of (223)Ra and the rate of hematotoxicity, but as to our knowl...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5882327/ https://ncbi.nlm.nih.gov/pubmed/29662636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24610 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|